#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vernal keratoconjunctivitis Short stature Myeloproliferative neoplasm Skin cancer Eosinophilic granulomatosis with polyangiitis Fungal infection Li-Fraumeni syndrome Follicle centre lymphoma follicular grade I II – III refractory Orthostatic hypotension Activated PI3 kinase delta syndrome Epstein-Barr virus infection Pouchitis Retinitis pigmentosa Infantile apnoea Pulmonary fibrosis More trials…

    Learn about Rare Diseases

    Phenylketonuria Rhabdoid tumour – Life with Disease Systemic mastocytosis – Trials in Disease Inclusion body myositis – Trials in Disease Haemophagocytic lymphohistiocytosis – Trials in Disease Glycogen storage disease type I Kearns-Sayre syndrome – Diagnostics Fabry’s disease – Life with Disease Rhabdoid tumour – Trials in Disease Methylmalonic acidaemia – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lorlatinib Antithymocyte Immunoglobulin Aavanc80-5'Hotof S095035 Dabigatran Etexilate Indacaterol Isatuximab Bi 3720931 Peposertib Sodium Fluoride (18F) Albumin Datopotamab Deruxtecan ULIXERTINIB Golimumab Abc-23A-116 Oric-114 Lsta1 Bepranemab Fampridine Ace Inhibitors, Plain More therapies…

    Learn about Your Condition

    Neuroendocrine tumour Facial paresis Oesophagectomy Transplant rejection Myotonia Hereditary ataxia Eosinophilic gastritis B-cell type acute leukaemia Immunodeficiency congenital Hepatotoxicity Loeys-Dietz syndrome Tardive dyskinesia Aneurysm ruptured Precocious puberty Meniere's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effects of Estradiol, Progesterone, and Online Sleep Therapy for Insomnia and Menopausal Symptoms in Perimenopausal Women

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Menopausal symptoms
    • Insomnia
    Investigated Drugs:
    • Estradiol
    • Progesterone, Micronised
    The Netherlands

  • Study on the Effects and Safety of Daratumumab, Bortezomib, and Dexamethasone for Patients with Relapsed or Refractory Plasmablastic Lymphoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasmablastic lymphoma
    Investigated Drugs:
    • Betamethasone Sodium Phosphate
    • Bortezomib
    • Daratumumab
    Italy

  • Study of Olverembatinib and Bosutinib for Patients with Chronic Phase Chronic Myeloid Leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic myeloid leukaemia
    Investigated Drugs:
    • OLVEREMBATINIB
    • Bosutinib
    Belgium France Germany Italy Poland Spain

  • Evaluation of Oxygen Administration Methods During One-Lung Ventilation in Patients Undergoing Lung Resection Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pulmonary resection
    Investigated Drugs:
    • Oxygen
    Spain

  • Study on Losartan and Hydrochlorothiazide for Osteogenesis Imperfecta in Patients Aged 16 and Above

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Hydrochlorothiazide
    • Losartan Potassium
    Italy

  • Study on Carvedilol for Preventing Complications in Patients with Early-Stage Cirrhosis and High Blood Pressure in the Liver

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cirrhosis alcoholic
    Investigated Drugs:
    • Carvedilol
    France
Previous Page
1 … 256 257 258 259 260 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!